Tumor and blood-derived dendritic cells for the immunotherapy of renal cell carcinoma

Tumor and blood-derived dendritic cells for the immunotherapy of renal cell carcinoma

Martin Thurnher (ORCID: 0000-0001-9940-7326)

Disciplines

Medical-Theoretical Sciences, Pharmacy (100%)

Keywords

    Dendritische Zellen Immuntherapie Nierentumor, Dendritische Zellen, Immuntherapie, Nierentumor

Research institution(s)

Research Output

  • 318 Citations
  • 4 Publications
Publications
  • 2001
    Title The disabled dendritic cell
    DOI 10.1096/fsb2fj000508hyp
    Type Journal Article
    Author Thurnher M
    Journal The FASEB Journal
    Pages 1054-1061
    Link Publication
  • 2001
    Title The disabled dendritic cell
    DOI 10.1096/fj.00-0508hyp
    Type Journal Article
    Author Thurnher M
    Journal The FASEB Journal
    Pages 1054-1061
  • 2001
    Title A clinically approved oral vaccine against pneumotropic bacteria induces the terminal maturation of CD83+ immunostimulatory dendritic cells
    DOI 10.1016/s0165-2478(00)00326-6
    Type Journal Article
    Author Zelle-Rieser C
    Journal Immunology Letters
    Pages 63-67
  • 1997
    Title Prostaglandin E2 and Tumor Necrosis Factor a Cooperate to Activate Human Dendritic Cells: Synergistic Activation of Interleukin 12 Production
    DOI 10.1084/jem.186.9.1603
    Type Journal Article
    Author Rieser C
    Journal The Journal of Experimental Medicine
    Pages 1603-1608
    Link Publication